Edition:
United States

Caroline Humer

U.S. seeks to cut dialysis costs with more home care versus clinics

Mar 04 2019

The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost care at home and transplants, a change that would upend a dialysis industry that provides care in thousands of clinics nationwide.

RPT-FOCUS-U.S. seeks to cut dialysis costs with more home care versus clinics

Mar 04 2019

March 4 The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost care at home and transplants, a change that would upend a dialysis industry that provides care in thousands of clinics nationwide.

FOCUS-U.S. seeks to cut dialysis costs with more home care versus clinics

Mar 04 2019

March 4 The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost care at home and transplants, a change that would upend a dialysis industry that provides care in thousands of clinics nationwide.

FOCUS-U.S. seeks to cut dialysis costs with more home care versus clinics

Mar 04 2019

March 4 The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost care at home and transplants, a change that would upend a dialysis industry that provides care in thousands of clinics nationwide.

CVS profit miss, rebate questions send shares tumbling 8 percent

Feb 20 2019

CVS Health Corp on Wednesday forecast 2019 profit well below Wall Street estimates due to weakness in its pharmacy business that serves long-term care facilities and slower than anticipated growth in drug prices, sending shares down 8 percent.

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

Feb 01 2019

NEW YORK A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

EXCLUSIVE-Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

Feb 01 2019

NEW YORK, Feb 1 A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.

REFILE-EXCLUSIVE-Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva

Feb 01 2019

NEW YORK, Feb 1 Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group Inc, has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an Optum client note viewed by Reuters.

U.S. government proposes rule overhauling drug industry rebate system

Jan 31 2019

NEW YORK/WASHINGTON The U.S. government on Thursday proposed a rule to end the industry-wide system of after-market discounts called rebates that pharmacy benefit managers (PBMs) receive from drugmakers, a practice that has been under increased scrutiny.

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen

Jan 25 2019

NEW YORK CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs, excluding a rival treatment from Amgen Inc, a CVS spokeswoman told Reuters on Friday.

World News

White House defers on release of Mueller's report, Kremlin warms

The White House said on Monday it was up to the U.S. Justice Department to decide if detailed findings from Special Counsel Robert Mueller's Russia investigation would be made public, a day after the attorney general said President Donald Trump had been cleared of any collusion.